Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol, November 16, 2011, Nicholls et al. 306 (19): 2099 — JAMA
Links shared publicly online about this topic.
- 0total visits
Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol, November 16, 2011, Nicholls et al. 306 (19): 2099 — JAMA
Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol, November 16, 2011, Nicholls et al. 306 (19): 2099 — JAMA
View full resource at jama.ama-assn.org
Tags: Cholesterol
Most Recently Shared on November 21, 2011 at 4:49 pm By:
This could be big time! http://t.co/N46MkCdk
Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol, November 16, 2011, Nicholls et al. 306 (19): 2099 — JAMA
jama.ama-assn.org — “Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol, November 16, 2011, Nicholls et al. 306 (19): 2099 — JAMA” View full resource at jama.ama-assn.org
Most Recently Shared on November 15, 2011 at 1:14 pm By:
New medication increases HDL and decreases LDL cholesterol levels. Paper presented at #AHA11 and JAMA publishes online: http://t.co/G7KmRwhu
Advertisement
